Boston Scientific Settles More Stent Patent Suits With J&J, For $1.7 Billion

The stent patent disarmament trend continued last week with the biggest settlement yet: Boston Scientific agreed Feb. 1 to pay Johnson & Johnson/Cordis $1.725 billion to settle three disputes dating back to 2003